Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 5736 · PAVE Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 1395x Definitions

+19 −5Shown
More for 42 U.S.C. § 1395x
Read § 1395xOnly this section
6 changes the bill asks for here, 6 carried out
  1. Carried out:

    by inserting penicillin allergy verification and evaluation (as defined in paragraph (5)), after (as defined in paragraph (4)),;

  2. Carried out:

    by redesignating subparagraph (O) as subparagraph (P); and

  3. Carried out:

    by inserting after subparagraph (N) the following new subparagraph:(O) Penicillin allergy verification and evaluation.; and

  4. Carried out:

    by adding at the end the following new paragraph:(5) For purposes of paragraph (1), the term “penicillin allergy verification and evaluation” means— (A) identification of individuals reporting a history of penicillin allergy; (B) consideration of whether the reported reaction history is consistent with an allergy or …

  5. Carried out:

    by redesignating subparagraph (I) as subparagraph (J); and

  6. Carried out:

    by inserting after subparagraph (H) the following new subparagraph:(I) Penicillin allergy verification and evaluation (as defined in subsection (ww)(5))..

§ 1395x(vv)–(ww)

Start of § 1395x to (vv)(2)(C)(ii) unchanged ·

(3) Subparagraphs (A) and (B) of paragraph (2) shall not apply in the case of an individual who, as of December 21, 2000, is licensed or certified as a dietitian or nutrition professional by the State in which medical nutrition therapy services are performed.

(ww) Initial preventive physical examination

(1) The term “initial preventive physical examination” means physicians’ services consisting of a physical examination (including measurement of height, weight body mass index,, and blood pressure) with the goal of health promotion and disease detection and includes education, counseling, and referral with respect to screening and other preventive services described in paragraph (2), end-of-life planning (as defined in paragraph (3)) upon the agreement with the individual, and the furnishing of a review of any current opioid prescriptions (as defined in paragraph (4)), [inserted: penicillin allergy verification and evaluation (as defined in paragraph (5)), ]but does not include clinical laboratory tests.

(2) The screening and other preventive services described in this paragraph include the following:

(A) Pneumococcal, influenza, and hepatitis B vaccine and administration under subsection (s)(10).

§ 1395x(ww)Initial preventive physical examination(2)–(3)

(ww)(2)(B)–(L) unchanged ·

(M) An electrocardiogram.

(N) Screening for potential substance use disorders.

(O) [inserted: Penicillin allergy verification and evaluation.]

[struck: (O)] [inserted: (P)] Additional preventive services (as defined in subsection (ddd)(1)).

(3) For purposes of paragraph (1), the term “end-of-life planning” means verbal or written information regarding—

(A) an individual’s ability to prepare an advance directive in the case that an injury or illness causes the individual to be unable to make health care decisions; and

§ 1395x(ww)–(xx)

(ww)(3)(B)–(4)(B) unchanged ·

(C) the provision of information on non-opioid treatment options; and

(D) a referral to a specialist, as appropriate.

(5) [inserted: For purposes of paragraph (1), the term “penicillin allergy verification and evaluation” means—]

(A) [inserted: identification of individuals reporting a history of penicillin allergy;]

(B) [inserted: consideration of whether the reported reaction history is consistent with an allergy or hypersensitivity reaction or can be reevaluated;]

(C) [inserted: the provision of information on the adverse individual and public health impact of a penicillin allergy label; and]

(D) [inserted: a referral to an allergy or immunology specialist, as appropriate.]

(xx) Cardiovascular screening blood test

(1) The term “cardiovascular screening blood test” means a blood test for the early detection of cardiovascular disease (or abnormalities associated with an elevated risk of cardiovascular disease) that tests for the following:

§ 1395x(hhh)Annual wellness visit(2)–(3)

(xx)(1)(A)–(hhh)(2)(F) unchanged ·

(G) Screening for potential substance use disorders and referral for treatment as appropriate.

(H) The furnishing of a review of any current opioid prescriptions (as defined in subsection (ww)(4)).

(I) [inserted: Penicillin allergy verification and evaluation (as defined in subsection (ww)(5)).]

[struck: (I)] [inserted: (J)] Any other element determined appropriate by the Secretary.

(3) A health professional described in this paragraph is—

(A) a physician;

Rest of § 1395x unchanged ·

Step through the changes